Antiarrhythmic effect of acute oxygen-ozone administration to rats

European Journal of Pharmacology

Volumn 629, Issue 1-3, 2010, Pages 89-95

  Di Filippo, Clara ^a   Cervone, Carmela ^a   Rossi, Claudia ^a   di Ronza, Cristina ^a   Marfella, Raffaele ^a   Capodanno, Paola ^a   Luongo, Carlo ^a   Rossi, Francesco ^a   D'Amico, Michele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

(Rats); Aconitine; Arrhythmias; Ischemia; Ozone; Potassium chloride; Reperfusion

Indexed keywords

ACONITINE; LIDOCAINE; OXYGEN; OZONE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG MIXTURE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INCIDENCE; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ACONITINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; MALE; MYOCARDIAL ISCHEMIA; OXYGEN; OZONE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 74149092497     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.061     Document Type: Article

References (44)

1. Ameri A. The effects of aconitum alkaloids on the central nervous system. Prog. Neurobiol. 56 (1998) 211-235
2. Amran M.S., Hashimoto K., and Homma N. Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies. J. Pharmacol. Exp. Ther. 310 (2004) 83-89
3. Andreula C.F., Simonetti L., De Santis F., Agati R., Ricci R., and Leonardi M. Minimally invasive oxygen-zone therapy for lumbar disk hernation. Am. J. Neuroradiol. 24 (2003) 996-1000
4. Arakawa J., Hara A., and Kokita N. Lidocaine attenuates mechanical and metabolic derangements induced by palmitoyl-l-carnitine in the isolated perfused rat heart. Pharmacology 55 (1997) 259-268
5. Barber E., Menendez S., Leon O.S., Barber M.O., Merino N., Calunga J.L., Cruz E., and Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediat. Inflamm. 8 (1999) 37-41
6. Bartosova L., Novak F., Bebarova M., Frydrych M., Brunclik V., Opatrilova R., Kolevska J., Mokry P., Kollar P., Strnadova V., and Suchy P. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia compared to lidocaine. Eur. J. Pharmacol. 575 (2007) 127-133
7. Baysan A., Whiley R.A., and Lynch E. Antimicrobial effect of a novel ozonegenerating device on micro-organisms associated with primary root carious lesions in vitro. Caries Res. 34 (2000) 498-501
8. Bocci V. Does ozone therapy normalize the cellular redox balance?Implications for therapy of human immunodeficiency virus infection and several other diseases. Med. Hypotheses 46 (1996) 150-154
9. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine?. Br. J. Biomed. Sci. 56 (1999) 270-279
10. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediat. Inflamm. 13 (2004) 3-11
11. Bocci V. The case for oxygen-ozonetherapy. Br. J. Biomed. Sci. 64 (2007) 44-49
12. D'Amico M., Di Filippo C., Rossi F., and Rossi F. Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. Eur. J. Pharmacol. 366 (1999) 167-174
13. Das D.K., and Misra H.P. Lidocaine: a hydroxyl radical scavenger and singlet oxygen quencher. Mol. Cell. Biochem. 115 (1992) 179-185
14. Dhalla N.S., Elmoselhi A.B., Hata T., and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 47 (2000) 446-456
15. Di Filippo C., Marfella R., Capodanno P., Ferraraccio F., Coppola L., Luongo M., Mascolo L., Luongo C., Capuano A., Rossi F., and D'Amico M. Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct. Inflamm. Res. 57 (2008) 445-449
16. Ebel D., Lipfert P., Fräßdorf J., Preckel B., Müllenheim J., Thämer V., and Schlack W. Lidocaine reduces ischaemic but not reperfusion injury in isolated rat heart. Br. J. Anaesth. 86 (2001) 846-852
17. Etheridge S.P., Compton S.J., Tristani-Firouzi M., and Mason J.W. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J. Am. Coll. Cardiol. 42 (2003) 1777-1782
18. 2+ homeostasis in the cardiac excitation-contraction coupling is a crucial mechanism of arrhythmic toxicity in aconitine-induced cardiomyocytes. Biochem. Biophys. Res. Commun. 354 (2007) 929-936
19. Hamada K., Yamazaki J., and Nagao T. Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a KATP channel opener. J. Mol. Cell. Cardiol. 30 (1998) 1369-1379
20. Hatori N., Roberts R.L., Tadokoro H., Ryden L., Satomura K., Fishbein M.C., Stiehm E.R., Corday E., and Drury J.K. Differences in infarct size with lidocaine as compared with bretylium tosylate in acute myocardial ischemia and reperfusion in pigs. J. Cardiovasc. Pharmacol. 18 (1991) 581-588
21. Hernandez F., Menendez S., and Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic. Biol. Med. 19 (1995) 115-119
22. Kojima M., and Miura M. Protective effect of lidocaine on the ischemic-reperfused rat heart: a phosphorus 31 nuclear magnetic resonance study. Basic Res. Cardiol. 28 (1993) 619-628
23. Latocha G., and Bernauer W. Effect of antiarrhythmic drugs on the postischaemic metabolic recovery of isolated rat hearts. Arch. Int. Pharmacodyn. 312 (1991) 39-54
24. Lee R., Nitta T., Schmid R.A., Schuessler R.B., Harris K.M., and Gay W.A. Retrograde infusion of lidocaine or l-arginine before reperfusion reduces myocardial infarct size. Ann. Thorac. Surg. 65 (1998) 1353-1359
25. Lin C.C., Chan T.Y., and Deng J.F. Clinical features and management of herb-induced aconitine poisoning. Ann. Emerg. Med. 43 (2004) 574-579
26. Liu Y., Du J., Gao Y., Zhang Y., Cai B.Z., Zhao H., Qi H.P., Du Z.M., Lu Y.J., and Yang B.F. Role of M(3) receptor in aconitine/barium-chloride-induced preconditioning against arrhythmias in rats. Naunyn Schmiedebergs Arch. Pharmacol. 379 (2009) 511-515
27. 2+-overload inhibitor, protects against aconitine-induced cardiac arrhythmias in vivo. J. Cardiovasc. Pharmacol. 22 (1993) 120-125
28. Moroz V.M., and Lipnitskii T.N. Simulation of cardiac hypopolarization arrhythmias and evaluation of cardiomyocyte membrane hypopolarization in experimental animals. Bull. Exp. Biol. Med. 142 (2006) 745-747
29. Ohmura T., Muramatsu I., Kigoshi S., Noguchi H., Muraoka R., Komoriya Y., and Hayashi H. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine. J. Pharmacol. Exp. Ther. 254 (1990) 696-701
30. Parrat J.R., Campbell C., and Fagbemi O. Catecholamines and early post-infaction arrhythmias: the effects of alpha- and beta-adrenoreceptors blockade. In: Delius W., Gerlach E., Grobecker H., and Kubler W. (Eds). Catecholamines and the heart: Recent Advances in Experimental and Clinical Research (1981), Springer, Berlin 269-282
31. Qu F., Qin X.Q., Cui Y.R., Xiang Y., Tan Y.R., Liu H.J., Peng L.H., Zhou X.Y., Liu C., and Zhu X.L. Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells. Chem. Biol. Interact. 179 (2009) 219-226
32. Romero Valdes A., Menendez Cepero S., Gomez Moraleda M., and Ley Pozo J. Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologia 45 (1993) 146-148
33. Sanguinetti M.C., and Bennett P.B. Antiarrhythmic drug target choices and screening. Circ. Res. 93 (2003) 491-499
34. 2+. Jpn. J. Physiol. 37 (1987) 59-79
35. Sugiyama K., and Muteki T. Local anesthetics depress the calcium current of rat sensory neurons in culture. Anesthesiology 80 (1994) 1369-1378
36. 3) aggravates inflammation in septic rats. Inflamm. Res. 53 (2004) S122-S125
37. Vitola J.V., Forman M.B., Holsinger J.P., Atkinson J.B., and Murray J.J. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am. Heart J. 133 (1997) 315-322
38. Walker M.J.A., Curtis M.J., Hearse D.G., Campbell R.W.F., Janse M.J., Yellon D.N., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parrat J.R., Riemersma R.A., Riva E., Russel D.C., Sheridan D.J., Winslow E., and Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
39. Wang S.Y., and Wang G.K. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell. Signal. 15 (2003) 151-159
40. 31P magnetic resonance spectroscopy study. Invest. Radiol. 28 (1993) 619-628
41. + ions. J. Physiol. 538 (2002) 759-771
42. Yang B.F., Lin H.X., Xiao J.N., Lu Y.J., Luo X.B., Li B.X., Zhang Y., Xu C.Q., Bai Y.L., Wang H.Z., Chen G.H., and Wang Z.G. The musclespecific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13 (2007) 486-491
43. Zamora Z.B., Borrego A., Lopez O.Y., Delgado R., Gonzalez R., Menendez S., Hernandez F., and Schulz S. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediat. Inflamm. 1 (2005) 16-22
44. Zhou S.S., Yang J., Li Y.Q., Zhao L.Y., Xu M., and Ding Y.F. Effect of Cl- channel blockers on aconitine-induced arrhythmias in rat heart. Exp. Physiol. 90 (2005) 865-872